|
|
 | | Targeting Health |  |
|
Provides health resources on spina bifida, including the four types of spina bifida (myelomeningocele or meningomyelocele, meningocele, lipomyelomeningocele, and occulta) and their characteristics, the possible causes and the role that folic acid can play in prevention, and information on treatment.
Provides information on spina bifida and hydrocephalus, including descriptions of the four most common types of spina bifida.
Source: Spina Bifida and Hydrocephalus Association of Canada
There is no cure for either spina bifida or hydrocephalus, a related condition, although there are measures women can take to help prevent spina bifida from developing in the fetus during pregnancy.
Source: HealthyOntario.com
What is spina bifida? What causes spina bifida? What are the symptoms? How is it diagnosed? Can spina bifida be prevented? How is it treated?
Source: Government of British Columbia - Ministry of Health Services
Spina bifida causes damage to the spinal cord and consequently, to other parts of the nervous system. There are however several forms of treatment available to help individuals with the secondary effects, and future moms can help reduce the risk of having a child with spina bifida by taking sufficient quantities of folic acid before conception.
Source: Spina Bifida And Hydrocephalus Association of Quebec
If you are a woman who may become pregnant, taking folic acid on a daily basis before pregnancy can help prevent serious birth defects in your unborn baby.
Source: Health Canada
This site provides information on neural tube defects (NTDs) and why folic acid is important in reducing the chances of having a baby born with NTDs.
Source: Government of British Columbia - Ministry of Health Services
Women who take folic acid supplements may reduce the risk of certain birth defects in their babies.
Source: Canadian Paediatric Society
Folic Acid, or folate, is one of the B vitamins that are important for healthy growth of your unborn baby.
Source: Public Health Agency of Canada
|
| |
|
|
|
